Projects per year
Fingerprint
Dive into the research topics where Kevin Cassady is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 4 Finished
-
Oncolytic virus bispecific gene delivery for high grade gliomas
Cripe, T. T. P. (PI), Cassady, K. (CoPI), Lee, D. A. (CoPI), Stein, L. D. (CoPI), Mardis, E. (CoPI), Cairo, M. S. (CoPI), Naeimi Kararoudi, M. (CoPI) & Sorensen, P. H. B. (CoPI)
09/12/19 → 08/31/24
Project: Research
-
Discovery and Development of Optimal Immunotherapeutic Strategies for Childhood Cancers
Maris, J. M. (PI), Cassady, K. (CoPI), Mackall, C. L. (CoPI) & Sondel, P. M. (CoPI)
09/20/18 → 08/31/23
Project: Research
-
Oncolytic Immunotherapy using Chimeric HSV C134: A Phase I Trial and Establishment of Response Indicators in Recurrent Glioma Patients
Markert, J. M. (PI) & Cassady, K. (CoPI)
09/18/18 → 08/31/21
Project: Research
-
HSV US11 MEDIATED EVASION OF HOST SHUTOFF
Cassady, K. (PI)
National Institute of Allergy and Infectious Diseases
08/1/99 → 07/31/01
Project: Research
-
Combinatorial immunotherapy with anti-ROR1 CAR NK cells and an IL-21 secreting oncolytic virus against neuroblastoma
Chu, Y., Tian, M., Saini, U., Ayala-Cuesta, J., Klose, K., Mendelowitz, A. S., Foley, K., Ozkaynak, M. F., Luo, W., Cripe, T. P., Lee, D. A., Cassady, K. A. & Cairo, M. S., Mar 20 2025, In: Molecular Therapy Oncology. 33, 1, 200927.Research output: Contribution to journal › Article › peer-review
Open Access -
Ruxolitinib and oHSV combination therapy increases CD4 T cell activity and germinal center B cell populations in murine sarcoma
Dhital, R., Kim, Y., Kim, D., Hernandez-Aguirre, I., Hedberg, J., Martin, A. & Cassady, K. A., Mar 20 2025, In: Molecular Therapy Oncology. 33, 1, 200929.Research output: Contribution to journal › Article › peer-review
Open Access -
Combinatorial macrophage induced innate immunotherapy against Ewing sarcoma: Turning “Two Keys” simultaneously
Luo, W., Hoang, H., Miller, K. E., Zhu, H., Xu, S., Mo, X., Garfinkle, E. A. R., Costello, H., Wijeratne, S., Chemnitz, W., Gandhi, R., Liao, Y., Ayello, J., Gardenswartz, A., Rosenblum, J. M., Cassady, K. A., Mardis, E. R., Lee, D. A., Cripe, T. P. & Cairo, M. S., Dec 2024, In: Journal of Experimental and Clinical Cancer Research. 43, 1, 193.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Corrigendum: Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors(Front. Immunol., (2024), 15, (1384623), 10.3389/fimmu.2024.1384623)
Paudel, S. N., Hutzen, B. J., Miller, K. E., Garfinkle, E. A. R., Chen, C. Y., Wang, P. Y., Glaspell, A. M., Currier, M. A., Ringwalt, E. M., Boon, L., Mardis, E. R., Cairo, M. S., Ratner, N., Dodd, R. D., Cassady, K. A. & Cripe, T. P., 2024, In: Frontiers in immunology. 15, 1456897.Research output: Contribution to journal › Comment/debate
Open Access -
Enhanced IL-12 transgene expression improves oncolytic viroimmunotherapy
Kim, Y., Saini, U., Kim, D., Hernandez-Aguirre, I., Hedberg, J., Martin, A., Mo, X., Cripe, T. P., Markert, J., Cassady, K. A. & Dhital, R., 2024, In: Frontiers in immunology. 15, 1375413.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations